To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MCM5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
239 representative clones for gene MCM5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA001599   .a 490 to 1073 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
AB209612 Spleen .d 43 to 4641 1 to 4598 F94L A95L A97P V98* tiling clone,   4598/4598
(100 %)
1 diff
(100.0 %id)
DA014395 adrenal gland .a 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AK122853 substantia nigra .b 10 to 2402 1 to 2393 E277D F588S tiling clone, available from FLJ,   2393/2393
(100 %)
4 diff
(99.9 %id)
AK223323 thymus .a 53 to 2576 1 to 2524 S146P R681P     2524/2524
(100 %)
2 diff
(100.0 %id)
AK291136   .a 62 to 2478 1 to 2417 S423P P508A     2417/2417
(100 %)
2 diff
(100.0 %id)
AK312533 tongue, tumor tissue .a 63 to 2341 1 to 2279 exact     2279/2279
(100 %)
3 diff
(99.9 %id)
DA031420   .a 63 to 634 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA038712   .a 92 to 658 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA049300   .a 95 to 661 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA051417   .a 63 to 650 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA078399 cerebellum .a 54 to 629 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA130139 alzheimer cortex .a 1475 to 2100 2 to 627   capped   626/626
(100 %)
0 diff
(100 %id)
DA154957 amygdala .a 67 to 645 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA173964 amygdala .a 54 to 634 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DC319579 brain .a 12 to 596 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DA274240 corpus callosum .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA305956 hippocampus .a 55 to 647 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA306825 hippocampus .a 54 to 632 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA349863 substantia nigra .b 11 to 605 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
BX111302 heart .a 1848 to 2508 1 to 662       662/671
(98 %)
2 diff
(99.8 %id)
DA419488 cord Blood .a 53 to 623 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CN275314 embryonic stem cells, DMSO-treated H9 cellline .d 1503 to 2169 1 to 667       667/667
(100 %)
2 diff
(99.8 %id)
CN276746 embryonic stem cells, DMSO-treated H9 cellline .d 3456 to 3943 1 to 488       488/488
(100 %)
0 diff
(100 %id)
CN283856 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1803 to 2460 1 to 658       658/658
(100 %)
0 diff
(100 %id)
CN304288 embryonic stem cells, DMSO-treated H9 cellline .a 117 to 860 9 to 752       744/752
(98 %)
5 diff
(99.4 %id)
CN304290 embryonic stem cells, DMSO-treated H9 cellline .a 873 to 1621 1 to 750       750/750
(100 %)
1 diff
(99.9 %id)
CN304294 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 71 to 642 1 to 572       572/572
(100 %)
0 diff
(100 %id)
CN304301 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 328 to 984 1 to 657       657/657
(100 %)
0 diff
(100 %id)
CN304302 embryonic stem cells, cell lines H1, H7, andH9 .a 130 to 694 1 to 565       565/565
(100 %)
0 diff
(100 %id)
CN304307 embryonic stem cells, cell lines H1, H7, andH9 .a 1306 to 1964 1 to 659       659/659
(100 %)
0 diff
(100 %id)
CN371317 embryonic stem cells, cell lines H1, H7, andH9 .d 2331 to 2532 1 to 202       202/204
(99 %)
2 diff
(99.1 %id)
CN371318 embryonic stem cells, DMSO-treated H9 cellline .d 2372 to 2785 1 to 414       414/414
(100 %)
1 diff
(99.8 %id)
CR456517   .a 103 to 2372 1 to 2270 exact     2270/2270
(100 %)
0 diff
(100 %id)
CR591959 Neuroblastoma Cot 10-normalized .a 78 to 2529 1 to 2452 exact     2452/2452
(100 %)
0 diff
(100 %id)
CR592264 T cells (Jurkat cell line) Cot10-normalized .a 1131 to 2559 1 to 1429       1429/1429
(100 %)
0 diff
(100 %id)
CR601762 Neuroblastoma Cot 25-normalized .c 1 to 2476 5 to 2480 exact tiling clone,   2480/2480
(100 %)
0 diff
(100 %id)
CR611599 Neuroblastoma Cot 10-normalized .a 101 to 2569 1 to 2469 exact     2469/2469
(100 %)
0 diff
(100 %id)
CR612297 B cells (Ramos cell line) .a 862 to 2575 1 to 1714       1714/1714
(100 %)
0 diff
(100 %id)
CR615349 Placenta Cot 25-normalized .a 43 to 2550 1 to 2508 exact     2508/2508
(100 %)
0 diff
(100 %id)
CR617289 Placenta Cot 25-normalized .b 1 to 2374 1 to 2374 exact tiling clone,   2374/2374
(100 %)
0 diff
(100 %id)
BX331344 Neuroblastoma Cot 10-normalized .a 71 to 981 1 to 907       907/907
(100 %)
4 diff
(99.6 %id)
CA389342 eye, RPE/choroid .k 252 to 905 1 to 654   tiling clone,   654/654
(100 %)
0 diff
(100 %id)
DA435311 tongue, tumor tissue .a 516 to 1107 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA440105 tongue, tumor tissue .a 56 to 669 2 to 615   capped   614/614
(100 %)
0 diff
(100 %id)
DA444049 tongue, tumor tissue .a 54 to 636 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA445206 tongue, tumor tissue .a 63 to 634 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA451901 tongue, tumor tissue .a 63 to 648 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
CV023160 mixed .a 137 to 758 1 to 622       622/627
(99 %)
2 diff
(99.7 %id)
DA462944   .d 106 to 666 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA464863   .a 64 to 631 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
D83986   .a 55 to 2587 1 to 2525 E527V S591T A593P R594V Q595S ...     2525/2525
(100 %)
14 diff
(99.5 %id)
DC349224   .a 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
0 diff
(100 %id)
DA478443   .a 63 to 631 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA479367   .a 65 to 636 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA481558   .a 53 to 623 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP230207 brain .a 62 to 642 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA504079 brain .a 63 to 639 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA508309 brain .a 66 to 650 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA541144 lung .a 89 to 669 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA550892   .a 54 to 879 2 to 827   capped   826/826
(100 %)
28 diff
(96.7 %id)
DA552973   .a 54 to 622 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BY799666 eye .a 78 to 678 1 to 601       601/601
(100 %)
0 diff
(100 %id)
DA576817   .a 243 to 812 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP872977 embryonal kidney .d 1851 to 2433 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC359039 lung .a 48 to 613 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA603259   .a 54 to 618 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
T84924 liver and spleen .d 3974 to 4301 1 to 334       334/339
(98 %)
9 diff
(97.4 %id)
T91947 liver and spleen .d 4438 to 4638 201 to 2       200/201
(99 %)
0 diff
(100 %id)
H57843 liver and spleen .d 4407 to 4628 223 to 1   fully sequenced,   223/223
(100 %)
4 diff
(98.3 %id)
H59968 liver and spleen .d 4041 to 4437 1 to 401   fully sequenced,   401/401
(100 %)
10 diff
(97.6 %id)
H71753 liver and spleen .d 4041 to 4338 1 to 296   fully sequenced,   296/296
(100 %)
2 diff
(99.4 %id)
H72316 liver and spleen .d 4308 to 4647 344 to 1   fully sequenced,   344/344
(100 %)
9 diff
(97.4 %id)
W78753 liver and spleen .d 4041 to 4400 1 to 368   fully sequenced,   368/368
(100 %)
13 diff
(96.5 %id)
W80586 liver and spleen .d 4370 to 4642 283 to 1   tiling clone, fully sequenced,   283/283
(100 %)
2 diff
(99.3 %id)
AI524725 B-cell, chronic lymphotic leukemia .d 4181 to 4641 481 to 21   AAA   461/461
(100 %)
5 diff
(99.0 %id)
AW673330 cervix .c 8 to 278 1 to 271       271/271
(100 %)
6 diff
(97.8 %id)
AW675690 cervix .c 1957 to 2501 545 to 1   tiling clone,   545/545
(100 %)
0 diff
(100 %id)
AW594038 pooled germ cell tumors .d 4258 to 4642 386 to 2       385/386
(99 %)
0 diff
(100 %id)
BE314967 adenocarcinoma cell line, ovary .a 1239 to 1868 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BE253723 eye, retinoblastoma .a 848 to 1640 1 to 790       790/792
(99 %)
12 diff
(98.5 %id)
BE535501 cervix .f 1 to 738 1 to 731 S191L A192R V193S R194V A195P ... tiling clone,   731/779
(93 %)
14 diff
(98.3 %id)
BE260388 brain, neuroblastoma .a 148 to 736 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BE297582 muscle, rhabdomyosarcoma .a 97 to 711 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BE388446 endometrium, adenocarcinoma cell line, uterus .a 1030 to 1696 1 to 664       664/664
(100 %)
7 diff
(99.0 %id)
BE389972 endometrium, adenocarcinoma cell line, uterus .a 81 to 711 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
BE390184 endometrium, adenocarcinoma cell line, uterus .a 101 to 732 1 to 632       632/657
(96 %)
0 diff
(100 %id)
BE736340 adenocarcinoma, Pancreas .g 1 to 711 3 to 703   tiling clone,   703/704
(99 %)
18 diff
(97.5 %id)
BE739897 adenocarcinoma cell line, ovary .a 513 to 1340 1 to 833       833/909
(91 %)
24 diff
(97.4 %id)
BG389992 embryonal carcinoma, cell line, testis .a 1728 to 2543 1 to 808       808/857
(94 %)
20 diff
(97.7 %id)
BG576914 breast, mammary adenocarcinoma, cell line .a 1556 to 2460 1 to 901       901/904
(99 %)
25 diff
(97.3 %id)
BG721685 testis .e 1 to 779 1 to 777 E3G L201S T202Q N203H I204C ... tiling clone,   777/777
(100 %)
7 diff
(99.1 %id)
BG760478 melanotic melanoma, high MDR (cell line), skin .a 511 to 1341 1 to 831       831/835
(99 %)
9 diff
(99.0 %id)
BG761438 melanotic melanoma, high MDR (cell line), skin .a 511 to 1092 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG770644 melanotic melanoma, high MDR (cell line), skin .a 1339 to 2119 8 to 787       780/925
(84 %)
16 diff
(98.3 %id)
BG770524 melanotic melanoma, high MDR (cell line), skin .a 511 to 1229 1 to 719       719/723
(99 %)
2 diff
(99.8 %id)
BG762639 melanotic melanoma, high MDR (cell line), skin .a 1715 to 2549 1 to 835       835/836
(99 %)
4 diff
(99.6 %id)
BG767144 melanotic melanoma, high MDR (cell line), skin .a 511 to 1341 1 to 834       834/840
(99 %)
8 diff
(99.1 %id)
BG769149 melanotic melanoma, high MDR (cell line), skin .a 1715 to 2477 1 to 757       757/759
(99 %)
11 diff
(98.6 %id)
BI772227 pooled lung and spleen .d 45 to 830 1 to 788       788/792
(99 %)
6 diff
(99.3 %id)
BI907841 leukocyte .d 87 to 824 1 to 742       742/743
(99 %)
17 diff
(97.8 %id)
BI869446 adenocarcinoma, cell line, Liver .a 1496 to 2279 1 to 786       786/786
(100 %)
2 diff
(99.8 %id)
BM917136 blood, natural killer cells, cell line .a 437 to 1323 1 to 897       897/1131
(79 %)
18 diff
(98.5 %id)
BM917819 blood, natural killer cells, cell line .a 675 to 1445 1 to 774       774/1026
(75 %)
11 diff
(99.0 %id)
BM480184 eye, retinoblastoma .a 86 to 1056 1 to 977       977/1079
(90 %)
15 diff
(98.7 %id)
BM799731 eye, retinoblastoma .a 2014 to 2587 1 to 574   AAA   574/574
(100 %)
0 diff
(100 %id)
BM456525 lymph, lymphoma, cell line .a 88 to 866 1 to 781       781/1047
(74 %)
17 diff
(98.4 %id)
BM457715 lymph, lymphoma, cell line .a 91 to 962 1 to 881       879/924
(95 %)
17 diff
(98.2 %id)
BM470663 leiomyosarcoma, uterus .a 82 to 993 1 to 917       917/984
(93 %)
12 diff
(98.8 %id)
BM558890 eye, retinoblastoma .a 82 to 1065 1 to 993       993/1004
(98 %)
14 diff
(98.7 %id)
BM802651 eye, retinoblastoma .a 1123 to 2105 1 to 981       981/1118
(87 %)
26 diff
(97.7 %id)
BM802048 eye, retinoblastoma .a 938 to 1723 1 to 791       791/967
(81 %)
23 diff
(97.7 %id)
BQ219621 leiomyosarcoma, uterus .a 90 to 1109 1 to 1025       1025/1029
(99 %)
20 diff
(98.1 %id)
BQ222354 leiomyosarcoma, uterus .a 67 to 1047 1 to 990       990/991
(99 %)
33 diff
(96.7 %id)
BM927583 lymph, lymphoma, cell line .a 70 to 888 1 to 821       821/1003
(81 %)
7 diff
(99.4 %id)
BM927634 lymph, lymphoma, cell line .a 70 to 944 1 to 882       882/1005
(87 %)
13 diff
(98.8 %id)
BQ069268 brain, neuroblastoma, cell line .a 72 to 980 1 to 919       919/1020
(90 %)
16 diff
(98.5 %id)
BQ059059 lymph, lymphoma, cell line .a 182 to 1172 1 to 1002       1002/1050
(95 %)
17 diff
(98.4 %id)
BQ065023 lymph, lymphoma, cell line .a 70 to 980 1 to 915       915/1001
(91 %)
8 diff
(99.3 %id)
BQ065931 lymph, lymphoma, cell line .a 72 to 980 1 to 912       912/1010
(90 %)
8 diff
(99.3 %id)
BQ066237 lymph, lymphoma, cell line .a 72 to 890 1 to 820       820/1003
(81 %)
3 diff
(99.8 %id)
BQ054136 blood, natural killer cells, cell line .a 847 to 1712 1 to 870       870/1082
(80 %)
14 diff
(98.8 %id)
BU190738 ductal carcinoma, cell line, Pancreas .a 687 to 1486 1 to 806       806/1040
(77 %)
14 diff
(98.7 %id)
BU179314 hepatocellular carcinoma, cell line, Liver .a 101 to 1163 1 to 1068       1068/1070
(99 %)
19 diff
(98.3 %id)
BU192073 embryonal carcinoma, cell line, testis .a 96 to 969 1 to 879       879/879
(100 %)
6 diff
(99.4 %id)
BQ213876 melanotic melanoma, skin .a 115 to 890 1 to 778       778/867
(89 %)
3 diff
(99.7 %id)
BQ232104 melanotic melanoma, skin .a 84 to 943 1 to 862       862/862
(100 %)
2 diff
(99.8 %id)
BQ223271 embryonal carcinoma, cell line, testis .a 571 to 1447 1 to 888       886/889
(99 %)
30 diff
(96.7 %id)
BU163845 epidermoid carcinoma, cell line, salivary gland .a 1011 to 1822 1 to 815       815/904
(90 %)
5 diff
(99.5 %id)
BU165017 eye, retinoblastoma .a 76 to 968 1 to 898       898/898
(100 %)
7 diff
(99.3 %id)
BU166135 melanotic melanoma, skin .a 112 to 928 1 to 825       825/834
(98 %)
9 diff
(99.0 %id)
BQ434878 leiomyosarcoma, uterus .a 96 to 963 1 to 873       873/873
(100 %)
7 diff
(99.2 %id)
BQ440710 melanotic melanoma, skin .a 89 to 887 1 to 808       808/913
(88 %)
15 diff
(98.4 %id)
BQ440728 melanotic melanoma, skin .a 62 to 943 1 to 887       887/889
(99 %)
11 diff
(98.8 %id)
BU156108 melanotic melanoma, skin .a 113 to 975 1 to 866       866/866
(100 %)
5 diff
(99.5 %id)
BU178502 melanotic melanoma, skin .a 83 to 973 1 to 900       898/902
(99 %)
18 diff
(98.1 %id)
BQ880654 ductal carcinoma, cell line, Pancreas .a 687 to 1549 1 to 869       869/889
(97 %)
16 diff
(98.3 %id)
BQ669996 epidermoid carcinoma, cell line, salivary gland .a 1248 to 2057 1 to 815       815/832
(97 %)
11 diff
(98.7 %id)
BQ672003 epidermoid carcinoma, cell line, salivary gland .a 1201 to 2041 1 to 845       845/848
(99 %)
11 diff
(98.8 %id)
BQ670216 epidermoid carcinoma, cell line, salivary gland .a 823 to 1693 1 to 881       881/908
(97 %)
22 diff
(97.6 %id)
BU174909 epidermoid carcinoma, cell line, salivary gland .a 1201 to 1901 1 to 708       708/1026
(69 %)
8 diff
(99.3 %id)
BQ645655 hepatocellular carcinoma, cell line, Liver .a 101 to 890 1 to 791       791/928
(85 %)
15 diff
(98.4 %id)
BQ683703 melanotic melanoma, cell line, skin .a 265 to 1056 1 to 792       792/931
(85 %)
10 diff
(99.0 %id)
BQ709833 Spleen .d 63 to 829 1 to 769       769/931
(82 %)
14 diff
(98.5 %id)
BQ707315 Spleen .d 63 to 821 1 to 775       773/961
(80 %)
26 diff
(97.3 %id)
BQ650287 hepatocellular carcinoma, cell line, Liver .a 79 to 890 1 to 815       815/997
(81 %)
18 diff
(98.2 %id)
BU839453 hepatocellular carcinoma, cell line, Liver .a 101 to 890 1 to 791       791/880
(89 %)
2 diff
(99.8 %id)
BQ645833 hepatocellular carcinoma, cell line, Liver .a 85 to 976 1 to 896       896/896
(100 %)
5 diff
(99.5 %id)
BQ643113 lymph, lymphoma, cell line .a 1968 to 2587 664 to 45   AAA Submitted on the opposite strand 620/869
(71 %)
0 diff
(100 %id)
BQ646119 hepatocellular carcinoma, cell line, Liver .a 85 to 889 1 to 807       807/971
(83 %)
12 diff
(98.8 %id)
BQ649375 hepatocellular carcinoma, cell line, Liver .a 101 to 980 1 to 881       881/962
(91 %)
11 diff
(98.9 %id)
BQ647973 hepatocellular carcinoma, cell line, Liver .a 101 to 1054 1 to 957       957/957
(100 %)
30 diff
(96.9 %id)
BQ709777 Spleen .d 62 to 829 16 to 786       771/919
(83 %)
13 diff
(98.6 %id)
BQ642797 lymph, lymphoma, cell line .a 72 to 978 1 to 914       914/920
(99 %)
12 diff
(98.7 %id)
BQ895922 carcinoma, cell line, Prostate .a 1298 to 2123 1 to 825       825/915
(90 %)
11 diff
(98.8 %id)
BU148519 carcinoma, cell line, Prostate .a 75 to 889 1 to 818       818/865
(94 %)
5 diff
(99.5 %id)
BQ935556 carcinoma, cell line, Prostate .a 1298 to 2176 1 to 882       882/926
(95 %)
25 diff
(97.4 %id)
BQ943544 carcinoma, cell line, Prostate .a 75 to 958 1 to 889       889/897
(99 %)
11 diff
(98.8 %id)
BQ957762 carcinoma, cell line, Prostate .a 75 to 967 1 to 894       894/894
(100 %)
5 diff
(99.5 %id)
BU538182 adenocarcinoma, cell line, breast .a 98 to 1035 1 to 943       943/943
(100 %)
8 diff
(99.2 %id)
BU541449 carcinoma, cell line, Prostate .a 75 to 978 1 to 913       913/917
(99 %)
10 diff
(99.0 %id)
BU845031 ovary, teratocarcinoma, cell line .a 63 to 889 1 to 827       827/918
(90 %)
2 diff
(99.8 %id)
BU556785 ovary, teratocarcinoma, cell line .a 72 to 889 1 to 819       819/896
(91 %)
4 diff
(99.6 %id)
BU557310 ovary, teratocarcinoma, cell line .a 72 to 944 1 to 879       879/880
(99 %)
7 diff
(99.3 %id)
BU557340 ovary, teratocarcinoma, cell line .a 303 to 1097 1 to 795       795/846
(93 %)
4 diff
(99.6 %id)
BU850061 ovary, teratocarcinoma, cell line .a 1758 to 2588 1 to 837       837/918
(91 %)
13 diff
(98.6 %id)
BU850199 ovary, teratocarcinoma, cell line .a 63 to 890 1 to 833       833/913
(91 %)
8 diff
(99.2 %id)
BU855896 ovary, teratocarcinoma, cell line .a 1930 to 2584 1 to 655   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BU932111 ovary, teratocarcinoma, cell line .a 1930 to 2583 1 to 653   AAA   653/653
(100 %)
1 diff
(99.9 %id)
CX164517 human embryonic stem cells differentiated toan early endodermal cell type .a 68 to 847 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CX785429 human embryonic stem cells .a 1175 to 1992 1 to 818       818/818
(100 %)
0 diff
(100 %id)
CX871261 embryonic stem .a 77 to 836 1 to 760       760/760
(100 %)
0 diff
(100 %id)
CX872671 embryonic stem .a 89 to 841 1 to 753       753/753
(100 %)
0 diff
(100 %id)
CX872598 embryonic stem .a 68 to 847 1 to 780       780/780
(100 %)
0 diff
(100 %id)
CX873547 embryonic stem .a 96 to 901 1 to 806       806/806
(100 %)
0 diff
(100 %id)
CV807265 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 769 to 1515 1 to 750       750/750
(100 %)
7 diff
(99.1 %id)
CX752905 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 111 to 866 1 to 749     Submitted on the opposite strand 749/767
(97 %)
17 diff
(97.8 %id)
DR156917 human embryonic stem cells differentiated toan early endodermal cell type .a 76 to 882 1 to 807       807/807
(100 %)
0 diff
(100 %id)
DR158737 human embryonic stem cells differentiated toan early endodermal cell type .a 77 to 700 1 to 624       624/624
(100 %)
0 diff
(100 %id)
DR159283 human embryonic stem cells differentiated toan early endodermal cell type .a 89 to 900 1 to 812       812/812
(100 %)
0 diff
(100 %id)
CU013405 Synthetic constructs .a 136 to 2338 19 to 2221       2203/2236
(98 %)
7 diff
(99.7 %id)
CU013117 Synthetic constructs .a 136 to 2341 19 to 2224 exact     2206/2239
(98 %)
7 diff
(99.7 %id)
DA612533   .a 54 to 624 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
TI_57180287   .d 45 to 830 64 to 851       788/855
(92 %)
12 diff
(98.6 %id)
TI_57234996   .d 87 to 824 30 to 771       742/772
(96 %)
23 diff
(97.1 %id)
TI_57238041   .d 5 to 594 33 to 623       591/851
(69 %)
9 diff
(99.0 %id)
TI_57228665   .a 1496 to 2279 48 to 833       786/786
(100 %)
2 diff
(99.8 %id)
DA620893   .a 104 to 695 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA620963   .j 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
BP282327 bone marrow .a 62 to 644 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP293932 lung .a 62 to 643 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA644000   .a 89 to 672 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA654936   .a 63 to 631 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BP304764   .d 75 to 649 1 to 574       574/575
(99 %)
11 diff
(98.1 %id)
DA670106   .h 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DA679035   .a 54 to 618 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
NM_006739.3   .a 43 to 2587 1 to 2545 exact RefSeq, AAA   2545/2545
(100 %)
0 diff
(100 %id)
AU126050   .a 454 to 1173 2 to 722   capped   721/821
(87 %)
4 diff
(99.6 %id)
AU149584   .a 1857 to 2586 734 to 1       734/735
(99 %)
16 diff
(97.9 %id)
AU132743   .a 86 to 890 2 to 807   capped   806/835
(96 %)
12 diff
(98.6 %id)
AU154216   .a 2066 to 2587 523 to 1       523/524
(99 %)
5 diff
(99.1 %id)
DA744920   .a 63 to 642 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA748404   .a 65 to 630 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA789579 brain .a 110 to 694 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DC380953 placenta .a 48 to 621 1 to 574       574/574
(100 %)
0 diff
(100 %id)
DA853264 placenta .a 54 to 623 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA861750 placenta .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA883950   .a 55 to 622 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CR984474 T-Lymphocytes .a 87 to 842 1 to 756       756/761
(99 %)
1 diff
(99.9 %id)
CR989869 T-Lymphocytes .a 87 to 695 1 to 609       609/615
(99 %)
1 diff
(99.9 %id)
BM787690 stomach .a 40 to 658 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM832544 stomach .a 103 to 675 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BM824441 Ascites, stomach .d 3184 to 3661 1 to 478       478/478
(100 %)
0 diff
(100 %id)
DA906951   .a 112 to 681 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA908197   .a 54 to 620 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA911528   .a 54 to 621 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA924061 small intestine .a 59 to 627 8 to 576   capped   569/569
(100 %)
0 diff
(100 %id)
BP338614 Spleen .i 1 to 468 1 to 468 S45X A49X S70X I84X A95V ... tiling clone,   468/552
(84 %)
22 diff
(96.1 %id)
DC388960 Spleen .a 48 to 613 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA935982 Spleen .a 54 to 645 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA936338 Spleen .d 139 to 706 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA941551 Spleen .a 54 to 645 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DC390213 Spleen .k 1 to 530 2 to 532 exact tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
DA953734 Spleen .d 135 to 690 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DC391445 Spleen .a 39 to 608 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DA959978 Spleen .d 139 to 677 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DA968920 stomach .a 66 to 641 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA977244 synovial membrane tissue from rheumatioidarthritis .a 65 to 635 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA985876 synovial membrane tissue from rheumatioidarthritis .d 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DC399469 testis .m 1 to 535 5 to 540 A37C S38F R39K S40E S41F ... tiling clone,   540/540
(100 %)
2 diff
(99.7 %id)
DB087147 testis .a 65 to 633 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB101038 thymus .a 57 to 584 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB342229 thymus .a 2084 to 2587 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
DB106824 thymus .a 63 to 630 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB111047 thymus .a 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB120905 thymus .a 63 to 638 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB135869 thymus .d 12 to 560 2 to 550   capped   549/549
(100 %)
11 diff
(98.0 %id)
DC408603 thymus .l 1 to 451 1 to 452 S43F A45G T46D P47A R48Q ... tiling clone,   452/452
(100 %)
2 diff
(99.6 %id)
DB160708 thymus .a 54 to 640 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DC410950 thymus .a 48 to 638 1 to 591       591/591
(100 %)
0 diff
(100 %id)
TI_154177993   .a 102 to 999 70 to 950       881/944
(93 %)
22 diff
(97.7 %id)
DC415166 trachea .a 43 to 639 1 to 598       596/598
(99 %)
0 diff
(100 %id)
BQ186483 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1677 to 2142 1 to 466   fully sequenced,   466/466
(100 %)
0 diff
(100 %id)
CK301002 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2081 to 2587 526 to 19   fully sequenced, AAA   508/508
(100 %)
2 diff
(99.7 %id)
BM683099 eye, fetal eye .a 1893 to 2587 714 to 19   AAA   696/696
(100 %)
2 diff
(99.8 %id)
BM719141 eye, fetal eye .a 780 to 1544 1 to 764       764/764
(100 %)
1 diff
(99.9 %id)
CA439402 lung, Metastatic Chondrosarcoma .a 1976 to 2587 630 to 19   AAA   612/612
(100 %)
1 diff
(99.9 %id)
BQ772212 Chondrosarcoma Cell line .a 1840 to 2587 765 to 19   AAA   747/753
(99 %)
1 diff
(99.9 %id)
X74795 cervix carcinoma .a 115 to 2587 1 to 2473 exact tiling clone, AAA   2473/2473
(100 %)
0 diff
(100 %id)
BU855896 ovary, teratocarcinoma, cell line .a 1930 to 2584 1 to 655   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BU855896 ovary, teratocarcinoma, cell line .a 1930 to 2584 1 to 655   AAA   655/655
(100 %)
1 diff
(99.9 %id)
BU932111 IMAGE:6672430 MCM5.aAug10 2583 653 IMAGE:6672430     653 1
BU932111 IMAGE:6672430 MCM5.aAug10 2583 653 IMAGE:6672430     653 1
CX164517 IMAGE:7468165 MCM5.aAug10 847 780 IMAGE:7468165     780 0
CX785429 IMAGE:7479999 MCM5.aAug10 1992 818 IMAGE:7479999     818 0
CX871261 IMAGE:7485657 MCM5.aAug10 836 760 IMAGE:7485657     760 0
CX872671 IMAGE:7487449 MCM5.aAug10 841 753 IMAGE:7487449     753 0
CX872598 IMAGE:7487472 MCM5.aAug10 847 780 IMAGE:7487472     780 0
CX873547 IMAGE:7488368 MCM5.aAug10 901 806 IMAGE:7488368     806 0
CV807265 IMAGE:7504727 MCM5.aAug10 1515 750 IMAGE:7504727     750 7
CV807265 IMAGE:7504727 MCM5.aAug10 1515 750 IMAGE:7504727     750 7
CX752905 IMAGE:7771990 MCM5.aAug10 866 749 IMAGE:7771990 Inverted   749 17
CX752905 IMAGE:7771990 MCM5.aAug10 866 749 IMAGE:7771990 Inverted   749 17
DR156917 IMAGE:7965567 MCM5.aAug10 882 807 IMAGE:7965567     807 0
DR158737 IMAGE:7967937 MCM5.aAug10 700 624 IMAGE:7967937     624 0
DR159283 IMAGE:7968212 MCM5.aAug10 900 812 IMAGE:7968212     812 0
CU013405 IMAGE:100000278 MCM5.aAug10 2338 2221 IMAGE:100000278     2203 7
CU013117 IMAGE:100000374 MCM5.aAug10 2341 2224 IMAGE:100000374     2206 7
DA612533 IMR322010920 MCM5.aAug10 624 572 IMR322010920     571 0
TI_57180287 INCYTE_603056183 MCM5.dAug10 830 851 INCYTE_603056183     788 12
TI_57234996 INCYTE_603066815 MCM5.dAug10 824 771 INCYTE_603066815     742 23
TI_57238041 INCYTE_603071055 MCM5.dAug10 594 623 INCYTE_603071055     591 9
TI_57228665 INCYTE_603393068 MCM5.aAug10 2279 833 INCYTE_603393068     786 2
DA620893 JCMLC2002732 MCM5.aAug10 695 593 JCMLC2002732     592 0
DA620963 JCMLC2002862 MCM5.jAug10 586 587 JCMLC2002862     586 1
BP282327 KMR03871 MCM5.aAug10 644 583 KMR03871     583 0
BP293932 LNG15273 MCM5.aAug10 643 582 LNG15273     582 0
DA644000 LYMPB2000785 MCM5.aAug10 672 585 LYMPB2000785     584 0
DA654936 MESAN2010235 MCM5.aAug10 631 570 MESAN2010235     569 0
BP304764 MPG02526 MCM5.dAug10 649 574 MPG02526     574 11
DA670106 NETRP2000133 MCM5.hAug10 553 554 NETRP2000133     553 0
DA679035 NHNPC2001133 MCM5.aAug10 618 566 NHNPC2001133     565 0
NM_006739.3 NM_006739 MCM5.aAug10 2587 2545 NM_006739     2545 0
AU126050 NT2RM4002629 MCM5.aAug10 1173 722 NT2RM4002629     721 4
AU149584 NT2RM4002629 MCM5.aAug10 2586 1 NT2RM4002629     734 16
AU132743 NT2RP4000459 MCM5.aAug10 890 807 NT2RP4000459     806 12
AU154216 NT2RP4000459 MCM5.aAug10 2587 1 NT2RP4000459     523 5
DA744920 NT2RP7009717 MCM5.aAug10 642 581 NT2RP7009717     580 0
DA748404 NT2RP7013740 MCM5.aAug10 630 567 NT2RP7013740     566 0
DA789579 OCBBF2027916 MCM5.aAug10 694 586 OCBBF2027916     585 0
DC380953 PLACE6015399 MCM5.aAug10 621 574 PLACE6015399     574 0
DA853264 PLACE7003428 MCM5.aAug10 623 571 PLACE7003428     570 0
DA861750 PLACE7014604 MCM5.aAug10 629 568 PLACE7014604     567 0
DA883950 PUAEN2003748 MCM5.aAug10 622 569 PUAEN2003748     568 0
CR984474 RZPDp9016J1735 MCM5.aAug10 842 756 RZPDp9016J1735     756 1
CR989869 RZPDp9016K1735 MCM5.aAug10 695 609 RZPDp9016K1735     609 1
BM787690 S11SNU1-17-C03 MCM5.aAug10 658 619 S11SNU1-17-C03     619 0
BM832544 S11SNU1-50-H09 MCM5.aAug10 675 573 S11SNU1-50-H09     573 0
BM824441 S22SNU16n1-95-D05 MCM5.dAug10 3661 478 S22SNU16n1-95-D05     478 0
BM824441 S22SNU16n1-95-D05 MCM5.dAug10 3661 478 S22SNU16n1-95-D05     478 0
DA906951 SKNMC2008310 MCM5.aAug10 681 571 SKNMC2008310     570 0
DA908197 SKNSH2000260 MCM5.aAug10 620 568 SKNSH2000260     567 0
DA911528 SKNSH2004929 MCM5.aAug10 621 569 SKNSH2004929     568 0
DA924061 SMINT2010466 MCM5.aAug10 627 576 SMINT2010466     569 0
BP338614 SPL02661 MCM5.iAug10 468 468 SPL02661     468 22
DC388960 SPLEN2000528 MCM5.aAug10 613 566 SPLEN2000528     566 0
DA935982 SPLEN2007832 MCM5.aAug10 645 593 SPLEN2007832     592 0
DA936338 SPLEN2008421 MCM5.dAug10 706 569 SPLEN2008421     568 0
DA941551 SPLEN2015800 MCM5.aAug10 645 593 SPLEN2015800     592 0
DC390213 SPLEN2018529 MCM5.kAug10 530 532 SPLEN2018529     532 1
DA953734 SPLEN2031793 MCM5.dAug10 690 557 SPLEN2031793     556 2
DC391445 SPLEN2034441 MCM5.aAug10 608 570 SPLEN2034441     570 0
DA959978 SPLEN2040227 MCM5.dAug10 677 540 SPLEN2040227     539 1
DA968920 STOMA2007797 MCM5.aAug10 641 577 STOMA2007797     576 0
DA977244 SYNOV2008126 MCM5.aAug10 635 572 SYNOV2008126     571 0
DA985876 SYNOV2018993 MCM5.dAug10 562 563 SYNOV2018993     562 0
DC399469 TESTI2048751 MCM5.mAug10 535 540 TESTI2048751     540 2
DB087147 TESTI4034985 MCM5.aAug10 633 570 TESTI4034985     569 0
DB101038 THYMU1000307 MCM5.aAug10 584 529 THYMU1000307     528 0
DB342229 THYMU1000307 MCM5.aAug10 2587 1 THYMU1000307     505 3
DB106824 THYMU2008344 MCM5.aAug10 630 569 THYMU2008344     568 0
DB111047 THYMU2014426 MCM5.aAug10 629 568 THYMU2014426     567 0
DB120905 THYMU2029265 MCM5.aAug10 638 577 THYMU2029265     576 0
DB135869 THYMU3006972 MCM5.dAug10 560 550 THYMU3006972     549 11
DC408603 THYMU3015366 MCM5.lAug10 451 452 THYMU3015366     452 2
DB160708 THYMU3040968 MCM5.aAug10 640 588 THYMU3040968     587 0
DC410950 THYMU3045863 MCM5.aAug10 638 591 THYMU3045863     591 0
TI_154177993 TI_154177993 MCM5.aAug10 999 950 TI_154177993     881 22
DC415166 TRACH2024157 MCM5.aAug10 639 598 TRACH2024157     596 0
BQ186483 UI-E-EJ1-ajr-c-24-0-UI MCM5.aAug10 2142 466 UI-E-EJ1-ajr-c-24-0-UI     466 0
BQ186483 UI-E-EJ1-ajr-c-24-0-UI MCM5.aAug10 2142 466 UI-E-EJ1-ajr-c-24-0-UI     466 0
CK301002 UI-E-EJ1-ajr-c-24-0-UI MCM5.aAug10 2587 19 UI-E-EJ1-ajr-c-24-0-UI     508 2
CK301002 UI-E-EJ1-ajr-c-24-0-UI MCM5.aAug10 2587 19 UI-E-EJ1-ajr-c-24-0-UI     508 2
BM683099 UI-E-EO1-ajd-m-16-0-UI MCM5.aAug10 2587 19 UI-E-EO1-ajd-m-16-0-UI     696 2
BM683099 UI-E-EO1-ajd-m-16-0-UI MCM5.aAug10 2587 19 UI-E-EO1-ajd-m-16-0-UI     696 2
BM719141 UI-E-EO1-ajd-m-16-0-UI MCM5.aAug10 1544 764 UI-E-EO1-ajd-m-16-0-UI     764 1
BM719141 UI-E-EO1-ajd-m-16-0-UI MCM5.aAug10 1544 764 UI-E-EO1-ajd-m-16-0-UI     764 1
CA439402 UI-H-DT1-avz-i-08-0-UI MCM5.aAug10 2587 19 UI-H-DT1-avz-i-08-0-UI     612 1
CA439402 UI-H-DT1-avz-i-08-0-UI MCM5.aAug10 2587 19 UI-H-DT1-avz-i-08-0-UI     612 1
BQ772212 UI-H-FE0-bbm-m-11-0-UI MCM5.aAug10 2587 19 UI-H-FE0-bbm-m-11-0-UI     747 1
X74795 X74795 MCM5.aAug10 2587 2473 X74795     2473 0
392 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI